Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
0.9601
-0.0100 (-1.03%)
At close: Aug 19, 2026, 4:00 PM EDT
0.9601
0.00 (0.00%)
Pre-market: Aug 20, 2026, 9:03 AM EDT

Bluejay Diagnostics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----0.25-
Revenue Growth
------
Gross Profit
----0.05-
Operating Income
-7.33-6.92-7.17-10.31-9.32-3.23
Net Income
-7.27-6.85-20.94-9.95-9.3-3.49
Earnings Per Share
-6.65-15.25-456.75---
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
9.65.164.32.2110.1119.05
Total Debt
0.080.130.240.370.51-
Net Cash (Debt)
9.525.044.071.849.619.05
Net Cash Growth
123.10%23.83%121.19%-80.85%-49.59%-
Net Cash Per Share
8.7011.2188.69---

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-5.9-6.05-7.82-8.31-7.74-4.37
Capital Expenditures
-0.34-0.17-0.31-0.7-1.2-0.02
Free Cash Flow
-6.24-6.23-8.13-9.02-8.94-4.39
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
----19.64%-
Operating Margin
-----3741.48%-
Pretax Margin
-----3733.11%-
Profit Margin
-----3733.11%-
FCF Margin
-----3590.13%-

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
----30.70-